John S. Poulter, D.D.S; Revocation of Registration, 24628-24629 [05-9248]
Download as PDF
24628
Federal Register / Vol. 70, No. 89 / Tuesday, May 10, 2005 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
John S. Poulter, D.D.S; Revocation of
Registration
On October 6, 2004, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to John S. Poulter,
D.D.S., (Dr. Poulter) notifying him of an
opportunity to show cause as to why
DEA should not revoke his DEA
Certification of Registration BP7418177,
pursuant to 21 U.S.C. 824(a)(2) and (4)
and deny any pending applications for
renewal of such registration pursuant to
21 U.S.C. 823(f). The order alleged in
relevant part that Dr. Poulter had been
arrested and convicted of several
offenses relating to the unlawful
possession and use of controlled
substances, including one felony
county; that he had been subject to
discplinary action by state licensing
authorities and that he violated DEA
record-keeping requirements. The order
also notified Dr. Poulter that should no
request for a hearing be filed within 30
days, his hearing right would be deemed
waived.
The Order to Show Cause was sent by
certified mail to Dr. Poulter at his
registered location in North Salt Lake
City, Utah. An undated, signed notice of
receipt was returned to DEA on October
26, 2004, indicating the Order to Show
Cause was received on his behalf. DEA
has not received a request for hearing or
any other reply from Dr. Poulter or
anyone purporting to represent him in
this matter.
Therefore, the Deputy Administrator
of DEA, finding that: (1) 30 days having
passed since the delivery of the Order
to Show Cause at Dr. Poulter’s registered
address, and (2) no request for hearing
having been received, concludes that Dr.
Poulter is deemed to have waived his
hearing right. See Samuel S. Jackson,
D.D.S., 67 FR 65145 (2002); David W.
Linder, 67 FR 12579 (2002). After
considering material from the
investigative file in this matter, the
Deputy Administrator now enters her
final order without a hearing pursuant
to 21 CFR 1301.43(d) and (e) and
1301.46.
Dr. Poulter is licensed under Utah law
as a dentist and currently holds DEA
Certificate of Registration BP7418177, as
a practitioner, to handle schedule II
through IV controlled substances. That
registration, last renewed in March
2004, expires on March 31, 2007. He
also holds a State of Utah Class IV
Anesthesia Permit.
VerDate jul<14>2003
17:09 May 09, 2005
Jkt 205001
On October 29, 2001, Dr. Poulter was
seen by witnesses parked in front of a
7-Eleven store in Woods Cross, Utah,
apparently injecting himself in the arm
with an unknown substance. Local law
enforcement authorities were called and
after failing a field sobriety test and
lying about taking a non-controlled
allergy medication, Dr. Poulter
eventually admitted that a vial
recovered from his car, labeled
‘‘Lidocaine,’’ actually contained
Demerol, a schedule II narcotic
controlled substance. He also admitted
injecting himself with Demerol while
seated in his automobile in front of the
convenience store.
Dr. Poulter was charged inthe Second
Judicial District Court of Davis County,
Utah, Case No. 011701966, with
Unlawful Possession or Use of a
Controlled Substance, to wit: Demerol, a
felony of the third degree. While that
charge was pending trial, Dr. Poulter
entered into a Diversion Agreement
with the Utah Division of Occupational
& Professional Licensing (DOPL). That
agreement, which was to run for a
period of five years, referred to ‘‘several
instances’’ of improper personal use of
Fentanyl (a schedule II narcotic
controlled substance) and Demerol by
Dr. Poulter. Among the agreement’s
terms, he was to abstain from personal
use or possession of mood altering
substances, including contolled
substances or illicit drugs, and could
not write, fill or otherwise order or
unlawfully obtain controlled substances
or mood altering substances for himself
or his family.
On February 11, 2002, Dr. Poulter
resolved the pending charge by entering
into a Plea in Abeyance Agreement and
Order with the prosecution. In exchange
for a plea of guilty to the third degree
felony of possession of a controlled
substance, his plea would be held in
abeyance by the court for up to 36
months. Dr. Poulter agreed not to violate
any laws and to complete all
requirements of a monitoring program
for impaired professionals established
by the state. Upon successful
completion of all provisions of the Plea
in Abeyance Agreement and Order, Dr.
Poulter’s guilty plea would be
withdrawn and the charge dismissed.
However, if he failed to successfully
complete the terms of the agreement, the
court would enter his plea of guilty and
proceed to sentencing on the felony.
On September 30, 2003, while the
terms of the Plea in Abeyance
Agreement and Order were in effect, Dr.
Poulter was involved in a single car
traffic accident in Utah County, Utah.
Responding officers and medical
personnel found him ‘‘incoherent and
PO 00000
Frm 00131
Fmt 4703
Sfmt 4703
very confused’’ and there were visible
needle marks on this left arm and both
hands. He was also wearing a fanny
pack with a syringe protruding through
it into his stomach area. A search of the
pack and his car revealed a bloody used
syringe and plastic container holding,
among other items, quantities of
Demerol and Fentanyl.
After injecting himself with drugs, Dr.
Poulter had fallen asleep while driving,
running his car off the road. He
admitted buying Fentanyl over the
Internet from a pharmacy in South
Carolina and to obtaining the Demerol
from a local hospital. A urine sample
was taken and toxicology results
corroborated the use of Demerol and
Fentanyl.
On February 2, 2004, Dr. Poulter was
charged in the Fourth Judicial District
Court for Utah County, Utah, Case No.
031403926 FS, with two felony counts
of possession or use of a controlled
substance (Demerol and Fentanyl) and
two misdemeanor counts of driving
under the influence of alcohol and/or
drugs and possession of drug
paraphernalia.
Based on the conduct which was the
basis for his September 2003 arrest, the
Second Judicial District Court then
found that Dr. Poulter has violated the
terms of his Plea in Abeyance and Order
and entered the guilty plea to the initial
felony charge. On July 19, 2004, that
court sentenced Dr. Poulter to an
indeterminate term in state prison, not
to exceed five years. However, it
suspended that sentence on condition
he serve four weekends in jail, perform
100 hours of community service and
complete eighteen months of supervised
probation.
On August 4, 2004, pursuant to a plea
agreement, the Fourth Judicial District
Court reduced the felony counts
pending in that court to misdemeanors
and sentenced him to 180 days in jail.
However, the court suspended 136 days
of that sentence and gave Dr. Poulter
credit for 40 days spent in a
rehabilitation clinic and one day of
actual incarceration, essentially
sentencing him to three days in jail,
along with a year’s probation.
On December 30, 2003, Dr. Poulter
met with DOPL investigators to discuss
his controlled substance record keeping
practices. He admitted to multiple
violations, including: Failure to
maintain complete and accurate records
of controlled substances received and
dispensed, in violation of 21 U.S.C.
827(a)(3) and 21 CFR 1304.04 and
1304.21; failure to take initial and
biennial inventories of controlled
E:\FR\FM\10MYN1.SGM
10MYN1
Federal Register / Vol. 70, No. 89 / Tuesday, May 10, 2005 / Notices
substances, as required by 21 U.S.C.
827(a)(1) and 21 CFR 1304.11; and
failure to preserve DEA order forms, as
required by 21 CFR 1305.13.
Pursuant to an April 20, 2004,
Stipulation and Order with DOPL, Dr.
Poulter’s state license to handle
controlled substances and his dental
license were revoked. However, the
revocation orders were stayed as to both
licenses and he was placed on probation
for a term of five years. He was again
ordered to abstain from personal use of
controlled substances and his
Anesthesia Permit was restricted to
certain enumerated drugs.
Pursuant to 21 U.S.C. 824(a)(2), the
Deputy Administrator may revoke a
DEA Certificate of Registration and deny
any pending applications for such a
certificate upon a finding that the
registrant has been convicted of a felony
related to controlled substances under
state or Federal law. The Deputy
Administrator finds Dr. Poulter has been
convicted of a state felony relating to
controlled substances and that
revocation of his registration is
appropriate under 21 U.S.C. 824(a)(2).
Additionally, the Deputy
Administrator may revoke a DEA
Certificate of Registration and deny any
pending applications for such certificate
if she determines that the issuance of
such registration would be inconsistent
with the public interest, as determined
pursuant to 21 U.S.C. 823(a)(4) and
823(f). Section 823(f) requires the
following factors be considered:
(1) The recommendation of the
appropriate state licensing board or
professional disciplinary authority.
(2) The applicant’s experience in
dispensing, or conducting research with
respect to controlled substances.
(3) The applicant’s conviction record
under Federal or State law relating to
the manufacture, distribution, or
dispensing of controlled substances.
(4) Compliance with applicable State,
Federal, or local laws relating to
controlled substances.
(5) Such other conduct which may
threaten the public health or safety.
As a threshold matter, it should be
noted that the factors specified in
section 823(f) are to be considered in the
disjunctive: The Deputy Administrator
may properly rely on any one or a
combination of the factors, and give
each factor the weight she deems
appropriate, in determining whether a
registration should be revoked or
denied. See Henry J. Schwarz, Jr., M.D.,
54 FR 16,422 (1989).
With regard to the public interest
factors of 21 U.S.C. 823(f), as to factor
one, recommendation of the state
licensing board/disciplinary authority,
VerDate jul<14>2003
16:17 May 09, 2005
Jkt 205001
it is noted that the Utah DOPL took
disciplinary action against Dr. Poulter.
However, it allowed his state dental
license and Anesthesia Permit to
continue in a probationary status, with
certain enumerated conditions.
Accordingly, to the extent that Utah has
allowed Dr. Poulter to continue
practicing dentistry and handle some
controlled substances, that weighs in
favor of continued registration with
DEA. However, ‘‘inasmuch as State
licensure is a necessary but not
sufficient condition for a DEA
registration * * * this factor is not
dispositive.’’ See Edson W. Redard,
M.D., 65 FR 30616, 30619.
Regarding factors two, three, four and
five, the conduct and actions discussed
earlier which resulted in his felony and
misdemeanor convictions are all
relevant and adverse to Dr. Poulter.
While the controlled substances were
apparently being diverted for personal
use and not for others, the record
reflects that simple opportunities and
leniency were extended Dr. Poulter by
the state criminal justice system and
Utah’s licensing authorities. He had an
excellent chance to address his
substance abuse problems with minimal
personal and professional impact.
Nevertheless, despite crystal clear
notice of the consequences of violating
the Plea in Abeyance Agreement and the
benefits of a rehabilitative and
monitoring program for impaired
professionals, Dr. Poulter threw away
the opportunities afforded him.
Instead of getting his personal and
professional life back on track, he chose
to resume abusing controlled substances
and whle doing so, endangered the
public by operating a motor vehicle
while under the influence of drugs.
Through his inability to refrain from
criminal and self-abusive behavior, Dr.
Poulter has demonstrated poor
judgment, questionable character and an
inability to comply with the
responsibilities of a DEA registrant.
In light of the foregoing, the Deputy
Administrator finds that Dr. Poulter’s
registration would be inconsistent with
the public interest, as that term is used
in 21 U.S.C. 823(f) and 824(a)(4).
Accordingly, the Deputy
Administrator of the Drug Enforcement
Administration, pursuant to the
authority vested in her by 21 U.S.C. 823
and 824 and 28 CFR 0.100(b) and 0.104,
hereby orders that DEA Certificate of
Registration BP7418177, previously
issued to John S. Poulter, D.D.C., be, and
it hereby is, revoked. The Deputy
Administrator further orders that any
pending applications for renewal or
modification of such registration be, and
PO 00000
Frm 00132
Fmt 4703
Sfmt 4703
24629
they hereby are, denied. This order is
effective June 9, 2005.
Dated: May 2, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05–9248 Filed 5–9–05; 8:45 am]
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Robert A. Smith, M.D.; Revocation of
Registration
On September 29, 2004, the Deputy
Administrator, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause/Immediate Suspension
of Registration to Robert A. Smith, M.D.
(Dr. Smith) who was notified of an
opportunity to show cause as to why
DEA should not revoke his DEA
Certificate of Registration AS2502284
under 21 U.S.C. 824(a)(4) and deny any
pending applications for renewal or
modification of that registration under
21 U.S.C. 823(f). Dr. Smith was further
notified that his registration was being
immediately suspended under 21 U.S.C.
824(d) as an imminent danger to the
public health and safety.
The Order to Show Cause alleged in
relevant part, that Dr. Smith diverted
controlled substances for a substantial
time by knowingly issuing fraudulent
prescriptions to individuals, without a
bona fide doctor-patient relationship or
legitimate medical purpose. The Order
to Show Cause also notified Dr. Smith
that should not request for a hearing be
filed within 30 days, his hearing right
would be deemed waived.
On October 20, 2004, a DEA
investigator personally served the Order
to Show Cause/Immediate Suspension
of Registration on Dr. Smith’s attorney
at Respondent’s medical office in
Philadelphia, Pennsylvania. Since that
date, DEA has not received a request for
a hearing or any other reply from Dr.
Smith or anyone purporting to represent
him in this matter.
Therefore, the Deputy Administrator
of DEA, finding that (1) thirty days
having passed since personal delivery of
the Order to Show Cause/Immediate
Suspension of Registration to the
registrant and (2) no request for hearing
having been received, concludes that Dr.
Smith is deemed to have waived his
hearing right. See David W. Linder, 67
FR 12579 (2002). After considering
material from the investigative file in
this matter, the Deputy Administrator
now enters her final order without a
hearing pursuant to 21 CFR 1301.43(d)
and (e) and 1301.46.
E:\FR\FM\10MYN1.SGM
10MYN1
Agencies
[Federal Register Volume 70, Number 89 (Tuesday, May 10, 2005)]
[Notices]
[Pages 24628-24629]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9248]
[[Page 24628]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
John S. Poulter, D.D.S; Revocation of Registration
On October 6, 2004, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to John S. Poulter, D.D.S., (Dr. Poulter) notifying
him of an opportunity to show cause as to why DEA should not revoke his
DEA Certification of Registration BP7418177, pursuant to 21 U.S.C.
824(a)(2) and (4) and deny any pending applications for renewal of such
registration pursuant to 21 U.S.C. 823(f). The order alleged in
relevant part that Dr. Poulter had been arrested and convicted of
several offenses relating to the unlawful possession and use of
controlled substances, including one felony county; that he had been
subject to discplinary action by state licensing authorities and that
he violated DEA record-keeping requirements. The order also notified
Dr. Poulter that should no request for a hearing be filed within 30
days, his hearing right would be deemed waived.
The Order to Show Cause was sent by certified mail to Dr. Poulter
at his registered location in North Salt Lake City, Utah. An undated,
signed notice of receipt was returned to DEA on October 26, 2004,
indicating the Order to Show Cause was received on his behalf. DEA has
not received a request for hearing or any other reply from Dr. Poulter
or anyone purporting to represent him in this matter.
Therefore, the Deputy Administrator of DEA, finding that: (1) 30
days having passed since the delivery of the Order to Show Cause at Dr.
Poulter's registered address, and (2) no request for hearing having
been received, concludes that Dr. Poulter is deemed to have waived his
hearing right. See Samuel S. Jackson, D.D.S., 67 FR 65145 (2002); David
W. Linder, 67 FR 12579 (2002). After considering material from the
investigative file in this matter, the Deputy Administrator now enters
her final order without a hearing pursuant to 21 CFR 1301.43(d) and (e)
and 1301.46.
Dr. Poulter is licensed under Utah law as a dentist and currently
holds DEA Certificate of Registration BP7418177, as a practitioner, to
handle schedule II through IV controlled substances. That registration,
last renewed in March 2004, expires on March 31, 2007. He also holds a
State of Utah Class IV Anesthesia Permit.
On October 29, 2001, Dr. Poulter was seen by witnesses parked in
front of a 7-Eleven store in Woods Cross, Utah, apparently injecting
himself in the arm with an unknown substance. Local law enforcement
authorities were called and after failing a field sobriety test and
lying about taking a non-controlled allergy medication, Dr. Poulter
eventually admitted that a vial recovered from his car, labeled
``Lidocaine,'' actually contained Demerol, a schedule II narcotic
controlled substance. He also admitted injecting himself with Demerol
while seated in his automobile in front of the convenience store.
Dr. Poulter was charged inthe Second Judicial District Court of
Davis County, Utah, Case No. 011701966, with Unlawful Possession or Use
of a Controlled Substance, to wit: Demerol, a felony of the third
degree. While that charge was pending trial, Dr. Poulter entered into a
Diversion Agreement with the Utah Division of Occupational &
Professional Licensing (DOPL). That agreement, which was to run for a
period of five years, referred to ``several instances'' of improper
personal use of Fentanyl (a schedule II narcotic controlled substance)
and Demerol by Dr. Poulter. Among the agreement's terms, he was to
abstain from personal use or possession of mood altering substances,
including contolled substances or illicit drugs, and could not write,
fill or otherwise order or unlawfully obtain controlled substances or
mood altering substances for himself or his family.
On February 11, 2002, Dr. Poulter resolved the pending charge by
entering into a Plea in Abeyance Agreement and Order with the
prosecution. In exchange for a plea of guilty to the third degree
felony of possession of a controlled substance, his plea would be held
in abeyance by the court for up to 36 months. Dr. Poulter agreed not to
violate any laws and to complete all requirements of a monitoring
program for impaired professionals established by the state. Upon
successful completion of all provisions of the Plea in Abeyance
Agreement and Order, Dr. Poulter's guilty plea would be withdrawn and
the charge dismissed. However, if he failed to successfully complete
the terms of the agreement, the court would enter his plea of guilty
and proceed to sentencing on the felony.
On September 30, 2003, while the terms of the Plea in Abeyance
Agreement and Order were in effect, Dr. Poulter was involved in a
single car traffic accident in Utah County, Utah. Responding officers
and medical personnel found him ``incoherent and very confused'' and
there were visible needle marks on this left arm and both hands. He was
also wearing a fanny pack with a syringe protruding through it into his
stomach area. A search of the pack and his car revealed a bloody used
syringe and plastic container holding, among other items, quantities of
Demerol and Fentanyl.
After injecting himself with drugs, Dr. Poulter had fallen asleep
while driving, running his car off the road. He admitted buying
Fentanyl over the Internet from a pharmacy in South Carolina and to
obtaining the Demerol from a local hospital. A urine sample was taken
and toxicology results corroborated the use of Demerol and Fentanyl.
On February 2, 2004, Dr. Poulter was charged in the Fourth Judicial
District Court for Utah County, Utah, Case No. 031403926 FS, with two
felony counts of possession or use of a controlled substance (Demerol
and Fentanyl) and two misdemeanor counts of driving under the influence
of alcohol and/or drugs and possession of drug paraphernalia.
Based on the conduct which was the basis for his September 2003
arrest, the Second Judicial District Court then found that Dr. Poulter
has violated the terms of his Plea in Abeyance and Order and entered
the guilty plea to the initial felony charge. On July 19, 2004, that
court sentenced Dr. Poulter to an indeterminate term in state prison,
not to exceed five years. However, it suspended that sentence on
condition he serve four weekends in jail, perform 100 hours of
community service and complete eighteen months of supervised probation.
On August 4, 2004, pursuant to a plea agreement, the Fourth
Judicial District Court reduced the felony counts pending in that court
to misdemeanors and sentenced him to 180 days in jail. However, the
court suspended 136 days of that sentence and gave Dr. Poulter credit
for 40 days spent in a rehabilitation clinic and one day of actual
incarceration, essentially sentencing him to three days in jail, along
with a year's probation.
On December 30, 2003, Dr. Poulter met with DOPL investigators to
discuss his controlled substance record keeping practices. He admitted
to multiple violations, including: Failure to maintain complete and
accurate records of controlled substances received and dispensed, in
violation of 21 U.S.C. 827(a)(3) and 21 CFR 1304.04 and 1304.21;
failure to take initial and biennial inventories of controlled
[[Page 24629]]
substances, as required by 21 U.S.C. 827(a)(1) and 21 CFR 1304.11; and
failure to preserve DEA order forms, as required by 21 CFR 1305.13.
Pursuant to an April 20, 2004, Stipulation and Order with DOPL, Dr.
Poulter's state license to handle controlled substances and his dental
license were revoked. However, the revocation orders were stayed as to
both licenses and he was placed on probation for a term of five years.
He was again ordered to abstain from personal use of controlled
substances and his Anesthesia Permit was restricted to certain
enumerated drugs.
Pursuant to 21 U.S.C. 824(a)(2), the Deputy Administrator may
revoke a DEA Certificate of Registration and deny any pending
applications for such a certificate upon a finding that the registrant
has been convicted of a felony related to controlled substances under
state or Federal law. The Deputy Administrator finds Dr. Poulter has
been convicted of a state felony relating to controlled substances and
that revocation of his registration is appropriate under 21 U.S.C.
824(a)(2).
Additionally, the Deputy Administrator may revoke a DEA Certificate
of Registration and deny any pending applications for such certificate
if she determines that the issuance of such registration would be
inconsistent with the public interest, as determined pursuant to 21
U.S.C. 823(a)(4) and 823(f). Section 823(f) requires the following
factors be considered:
(1) The recommendation of the appropriate state licensing board or
professional disciplinary authority.
(2) The applicant's experience in dispensing, or conducting
research with respect to controlled substances.
(3) The applicant's conviction record under Federal or State law
relating to the manufacture, distribution, or dispensing of controlled
substances.
(4) Compliance with applicable State, Federal, or local laws
relating to controlled substances.
(5) Such other conduct which may threaten the public health or
safety.
As a threshold matter, it should be noted that the factors
specified in section 823(f) are to be considered in the disjunctive:
The Deputy Administrator may properly rely on any one or a combination
of the factors, and give each factor the weight she deems appropriate,
in determining whether a registration should be revoked or denied. See
Henry J. Schwarz, Jr., M.D., 54 FR 16,422 (1989).
With regard to the public interest factors of 21 U.S.C. 823(f), as
to factor one, recommendation of the state licensing board/disciplinary
authority, it is noted that the Utah DOPL took disciplinary action
against Dr. Poulter. However, it allowed his state dental license and
Anesthesia Permit to continue in a probationary status, with certain
enumerated conditions. Accordingly, to the extent that Utah has allowed
Dr. Poulter to continue practicing dentistry and handle some controlled
substances, that weighs in favor of continued registration with DEA.
However, ``inasmuch as State licensure is a necessary but not
sufficient condition for a DEA registration * * * this factor is not
dispositive.'' See Edson W. Redard, M.D., 65 FR 30616, 30619.
Regarding factors two, three, four and five, the conduct and
actions discussed earlier which resulted in his felony and misdemeanor
convictions are all relevant and adverse to Dr. Poulter. While the
controlled substances were apparently being diverted for personal use
and not for others, the record reflects that simple opportunities and
leniency were extended Dr. Poulter by the state criminal justice system
and Utah's licensing authorities. He had an excellent chance to address
his substance abuse problems with minimal personal and professional
impact. Nevertheless, despite crystal clear notice of the consequences
of violating the Plea in Abeyance Agreement and the benefits of a
rehabilitative and monitoring program for impaired professionals, Dr.
Poulter threw away the opportunities afforded him.
Instead of getting his personal and professional life back on
track, he chose to resume abusing controlled substances and whle doing
so, endangered the public by operating a motor vehicle while under the
influence of drugs. Through his inability to refrain from criminal and
self-abusive behavior, Dr. Poulter has demonstrated poor judgment,
questionable character and an inability to comply with the
responsibilities of a DEA registrant.
In light of the foregoing, the Deputy Administrator finds that Dr.
Poulter's registration would be inconsistent with the public interest,
as that term is used in 21 U.S.C. 823(f) and 824(a)(4).
Accordingly, the Deputy Administrator of the Drug Enforcement
Administration, pursuant to the authority vested in her by 21 U.S.C.
823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA
Certificate of Registration BP7418177, previously issued to John S.
Poulter, D.D.C., be, and it hereby is, revoked. The Deputy
Administrator further orders that any pending applications for renewal
or modification of such registration be, and they hereby are, denied.
This order is effective June 9, 2005.
Dated: May 2, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 05-9248 Filed 5-9-05; 8:45 am]
BILLING CODE 4410-09-M